Classes
Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Prevention of atherosclerosis2012 | First Faculty of Medicine
- Modern risk factors of atherosclerosis2012 | First Faculty of Medicine
- Rosuvastatine2009 | First Faculty of Medicine
- Clinical studies, evidence based medicina expectations and reality2009 | First Faculty of Medicine
- Treatment of HLP and DLP in 20092009 | First Faculty of Medicine
- Recommendations for diagnosis and treatment of dyslipidemia in children and adolescents prepared by the commitee of the Czech society for atherosclerosis2008 | First Faculty of Medicine
- Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatment2008 | First Faculty of Medicine
- Woman, lipids and atherosclerosis2008 | First Faculty of Medicine
- Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...